Skip to main content English

Detail

Lukas E. Schmidt
Lukas E. Schmidt, MSc RSci

Department of Medicine II (Division of Cardiology)
Position: PHD Student

ORCID: 0000-0001-7565-1455
lukas.schmidt@muv.ac.at

Keywords

Apolipoproteins; Atherosclerosis; Chromatography; Hypolipidemic Agents; Lipoproteins; Mass Spectrometry; Proteomics

Selected publications

  1. d’Escamard, V. et al. (2024) ‘Integrative gene regulatory network analysis discloses key driver genes of fibromuscular dysplasia’, Nature Cardiovascular Research, 3(9), pp. 1098–1122. Available at: https://doi.org/10.1038/s44161-024-00533-w.
  2. Foote, K. et al. (2024) ‘Oxidative DNA damage promotes vascular ageing associated with changes in extracellular matrix-regulating proteins’, Cardiovascular Research, 121(4), pp. 614–628. Available at: https://doi.org/10.1093/cvr/cvae091.
  3. Theofilatos, K. et al. (2023) ‘Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes’, Circulation Research, 133(7), pp. 542–558. Available at: https://doi.org/10.1161/circresaha.123.322590.
  4. Schmidt, L.E. et al. (2023) ‘Reducing reductionism: addressing risk for atherosclerotic cardiovascular disease by apolipoprotein proteomics’, European Heart Journal, 44(27), pp. 2420–2422. Available at: https://doi.org/10.1093/eurheartj/ehad294.
  5. Clarke, R. et al. (2023) ‘Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease’, Circulation Research, 132(4), pp. 452–464. Available at: https://doi.org/10.1161/circresaha.122.321690.